This weeks CotW is from our recent webinar.  This figure demonstrates the results of an analysis focused on identifying biomarkers that are measured together frequently in clinical trials.  The goal of the analysis was to identify groups of biomarkers that are linked by both co-occurrence in trials, and also by shared functional attributes.  These biomarkers are all measured together in at least three recent clinical trials, and the size of the line connecting each biomarker pair indicates the total number of trials in which each pair is measured (i.e thicker = more trials).  The biomarkers are also color-coded based on shared biological functions.

Screen_Shot_2016-05-03_at_11.42.16_AM.png

Share this Image On Your Site

<p><strong>Please include attribution to amplion.com with this graphic.</strong><br /><br /><a href=’https://amplion.wpengine.com/biomarker-trends/chart-of-the-week-panel-opportunities-in-lung-cancer’><img src=’https://amplion.com/wp-content/uploads/2016/05/Screen_Shot_2016-05-03_at_11.42.16_AM.png’ alt=’Biomarker co-occurance in lung cancer’ width=’540px’ border=’0′ /></a></p>

For analysis like this for your projects:

[plsc_button url=”https://amplion.wpengine.com/consulting?hsCtaTracking=0ecabe42-acda-48e9-b2bd-1a020165bdb3%7Cb6240f02-690a-44c9-8446-a7209594c70a” target=”_blank” color=”green” style=”flat” radius=”square” size=”lg”]TALK TO A CONSULTANT[/plsc_button]

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access